Literature DB >> 2468972

Hypertensive heart disease: the critical role of left ventricular hypertrophy.

B M Massie1, J F Tubau, J Szlachcic, B F O'Kelly.   

Abstract

The presence of left ventricular hypertrophy in hypertensive patients has been linked with increased likelihood for developing congestive heart failure, the potential for myocardial ischemia and the inherent risk for sudden death. In this paper we review current knowledge regarding the role of left ventricular hypertrophy in cardiac morbidity and mortality and emphasize the need for further study to explore the efficacy of pharmaceutical agents in reducing cardiac complications of hypertension in high-risk patients.

Entities:  

Mesh:

Year:  1989        PMID: 2468972

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart.

Authors:  J R Payne; K I Eleftheriou; L E James; E Hawe; J Mann; A Stronge; P Kotwinski; M World; S E Humphries; D J Pennell; H E Montgomery
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

2.  Determination of rat heart morphology and function in vivo in two models of cardiac hypertrophy by means of magnetic resonance imaging.

Authors:  M Rudin; B Pedersen; K Umemura; W Zierhut
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

3.  Left ventricular function in dogs 1 year after coarctectomy.

Authors:  M Leskinen; M Uhari; M Tarkka; R Kettunen
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

Review 4.  Primary prevention potential of the calcium antagonists. Effects on blood pressure and lipid pattern.

Authors:  K Midtbø
Journal:  Drugs       Date:  1992       Impact factor: 9.546

5.  Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.

Authors:  Takeshi Takami; Yoshihiko Saito
Journal:  Drug Des Devel Ther       Date:  2013-03-22       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.